Partial or total protection from long-acting monoamine oxidase inhibitors (MAOIs) by new short-acting MAOIs of type A MD780515 and type B MD780236. - Suppr | 超能文献

Partial or total protection from long-acting monoamine oxidase inhibitors (MAOIs) by new short-acting MAOIs of type A MD780515 and type B MD780236.

作者信息

Benedetti M S, Dostert P, Guffroy C, Tipton K F

出版信息

Mod Probl Pharmacopsychiatry. 1983;19:82-104. doi: 10.1159/000407506.

DOI:10.1159/000407506

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Partial or total protection from long-acting monoamine oxidase inhibitors (MAOIs) by new short-acting MAOIs of type A MD780515 and type B MD780236.

Mod Probl Pharmacopsychiatry. 1983;19:82-104. doi: 10.1159/000407506.

2

Antagonism between long acting monoamine oxidase inhibitors (MAOI) and MD780515, a new specific and reversible MAOI.

Life Sci. 1980 Jun 23;26(25):2165-71. doi: 10.1016/0024-3205(80)90604-9.

3

Monoamine oxidase inhibitors and histamine metabolism.单胺氧化酶抑制剂与组胺代谢

Experientia. 1980 Jul 15;36(7):818-10. doi: 10.1007/BF01978589.

4

SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.SR 95191，一种具有多巴胺能特性的A型单胺氧化酶选择性抑制剂。II. 单胺氧化酶抑制作用的生化特性

J Pharmacol Exp Ther. 1987 Jan;240(1):251-8.

5

Characteristics of the inhibition of rat brain monoamine oxidase in vitro by MD780515.MD780515在体外对大鼠脑单胺氧化酶的抑制特性。

J Neurochem. 1981 Apr;36(4):1561-71. doi: 10.1111/j.1471-4159.1981.tb00599.x.

6

The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone.大鼠脑中两种单胺氧化酶对多巴胺的代谢及其受西莫沙酮的抑制作用。

J Neurochem. 1983 Jun;40(6):1534-41. doi: 10.1111/j.1471-4159.1983.tb08123.x.

7

Cimoxatone is a reversible tight-binding inhibitor of the A form of rat brain monoamine oxidase.西莫沙酮是大鼠脑单胺氧化酶A形式的一种可逆性紧密结合抑制剂。

J Neurochem. 1983 Feb;40(2):510-3. doi: 10.1111/j.1471-4159.1983.tb11312.x.

8

Metabolism of the monoamine oxidase-B inhibitor, MD 780236 and its enantiomers by the A and B forms of the enzyme in the rat.

J Pharm Pharmacol. 1983 Dec;35(12):837-40. doi: 10.1111/j.2042-7158.1983.tb02911.x.

9

Enhancement of 5-HT-induced anorexia: a test of the reversibility of monoamine oxidase inhibitors.5-羟色胺诱导的厌食症增强：单胺氧化酶抑制剂可逆性的一项测试。

Psychopharmacology (Berl). 1989;98(2):265-8. doi: 10.1007/BF00444703.

10

Cumulative effects of irreversible MAO inhibitors in vivo.

Biochem Pharmacol. 1979 Apr 1;28(7):995-1002. doi: 10.1016/0006-2952(79)90293-4.

引用本文的文献

1

Estimation of the elimination half-life of the monoamine oxidase inhibitor cimoxatone in rat brain on the basis of ex vivo inhibition data.基于体外抑制数据估算单胺氧化酶抑制剂西莫沙酮在大鼠脑中的消除半衰期。

Eur J Drug Metab Pharmacokinet. 1983 Oct-Dec;8(4):389-93. doi: 10.1007/BF03188771.

2

Selective inhibition by amiflamine of monoamine oxidase type A in rat brain, liver and duodenum.阿米氟明对大鼠脑、肝和十二指肠中A型单胺氧化酶的选择性抑制作用。

Naunyn Schmiedebergs Arch Pharmacol. 1984 Aug;327(1):56-63. doi: 10.1007/BF00504992.